91 related articles for article (PubMed ID: 32208562)
1. Insulin Adverse Events.
Ludvigsson J
Pediatr Endocrinol Rev; 2020 Mar; 17(Suppl 1):183-190. PubMed ID: 32208562
[TBL] [Abstract][Full Text] [Related]
2. Reconsideration of severe hypoglycemic events in the treat-to-target trial.
Dailey G; Strange P; Riddle M
Diabetes Technol Ther; 2009 Aug; 11(8):477-9. PubMed ID: 19698059
[TBL] [Abstract][Full Text] [Related]
3. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.
Pfützner A; Hermanns N; Funke K; Forst T; Behnke T; Bitton G; Nagar R; Raz I; Haak T
Curr Med Res Opin; 2014 May; 30(5):753-60. PubMed ID: 24392996
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges.
Blumer I; Clement M
Clin Ther; 2017 Aug; 39(8S2):S1-S11. PubMed ID: 27871780
[TBL] [Abstract][Full Text] [Related]
5. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia and insulin analogues: is there a reduction in the incidence?
Heinemann L
J Diabetes Complications; 1999; 13(2):105-14. PubMed ID: 10432175
[TBL] [Abstract][Full Text] [Related]
7. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemia: Adverse Cardiovascular Outcomes in Non-Critically Ill People with Type 2 Diabetes.
Akhavan P; Aghili R; Malek M; Ebrahim Valojerdi A; Khamseh ME
Arch Iran Med; 2016 Feb; 19(2):82-6. PubMed ID: 26838076
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
Harris C; Forst T; Heise T; Plum-Mörschel L; Watkins E; Zhang Q; Fan L; Garhyan P; Porksen N
Diabetes Technol Ther; 2017 Aug; 19(8):463-470. PubMed ID: 28817342
[TBL] [Abstract][Full Text] [Related]
10. [Insulin therapy-new insulin analogues].
Ehren M; Klein HH
Internist (Berl); 2019 Sep; 60(9):887-894. PubMed ID: 31396651
[TBL] [Abstract][Full Text] [Related]
11. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemia: New Definitions and Regulatory Implications.
Ratner RE
Diabetes Technol Ther; 2018 Jun; 20(S2):S250-S253. PubMed ID: 29873525
[TBL] [Abstract][Full Text] [Related]
13. Insulin lispro: a fast-acting insulin analog.
Noble SL; Johnston E; Walton B
Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
[TBL] [Abstract][Full Text] [Related]
14. Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.
Ranjan A
Dan Med J; 2018 Feb; 65(2):. PubMed ID: 29393039
[TBL] [Abstract][Full Text] [Related]
15. [Long-acting insulin analogs: progressing slowly].
Holleman F; Hoekstra JB
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
McKeage K; Goa KL
Treat Endocrinol; 2002; 1(1):55-8. PubMed ID: 15765621
[TBL] [Abstract][Full Text] [Related]
17. [Type 2 diabetes: what therapeutic strategy?].
Grimaldi A; Hartemann-Heurtier A
Presse Med; 2001 Feb; 30(6):288-97. PubMed ID: 11252980
[TBL] [Abstract][Full Text] [Related]
18. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
19. Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice.
Ross S; Dzida G; Ji Q; Kaiser M; Ligthelm R; Meneghini L; Nazeri A; Orozco-Beltran D; Pan C; Svendsen AL;
J Diabetes; 2014 May; 6(3):243-50. PubMed ID: 24103141
[TBL] [Abstract][Full Text] [Related]
20. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study.
Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F
Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
